
ICON Public Limited Company ICLR
€ 86.56
-0.59%
Geschäftsbericht 2024
hinzugefügt 18.04.2026
ICON Public Limited Company DSO 2011-2026 | ICLR
DSO Jährlich ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 68.5 | 81.1 | 61.3 | 55.8 | 82.6 | 145 | 148 | 134 | 131 | 141 | 135 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 148 | 55.8 | 107 |
DSO Vierteljährlich ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 65.1 | - | 49.3 | 70 | 73.1 | - | 64 | 73.5 | 67.2 | - | 53.9 | 55.6 | 56.1 | - | 54.2 | 56.8 | 56.9 | - | 73 | 74.1 | 79.9 | - | 83.7 | 81 | 87.9 | - | 86.1 | 84.5 | 86.1 | - | 89 | 87.4 | 88.8 | - | 89.4 | 77.4 | 78.7 | - | 73.4 | 69.7 | 71.7 | - | 69.7 | 70.3 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 89.4 | 49.3 | 72.7 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
63.8 | $ 115.6 | 0.06 % | $ 35.1 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 1.65 | -1.2 % | $ 2.19 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 24.8 | 1.39 % | $ 689 M | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 21.22 | -0.05 % | $ 1.13 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Illumina
ILMN
|
61.3 | $ 127.82 | -0.05 % | $ 20.3 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.81 | -3.07 % | $ 478 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 84.53 | 0.24 % | $ 5.7 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 170.09 | 0.19 % | $ 8.43 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 417.28 | 1.64 % | $ 12 B | ||
|
Guardant Health
GH
|
46.1 | $ 89.33 | 0.47 % | $ 11.2 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 1.93 | -2.08 % | $ 8.54 M | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 7.17 | 1.7 % | $ 299 M | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Soleno Therapeutics
SLNO
|
27 | $ 52.75 | 0.05 % | $ 2.68 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.51 | -0.37 % | $ 2.06 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.15 | 0.7 % | $ 4.94 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 467.93 | -0.35 % | $ 176 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.07 | -0.93 % | $ 382 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 263.9 | 0.06 % | $ 22 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.65 | 0.95 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 60.76 | -0.3 % | $ 3.63 B | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 8.57 | 3.44 % | $ 1.1 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.76 | -0.42 % | $ 441 M | ||
|
Natera
NTRA
|
81.5 | $ 204.88 | 0.55 % | $ 20.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 196.9 | 0.35 % | $ 21.9 B | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B |